STOCK TITAN

Natera (NASDAQ: NTRA) shares preliminary Q4 and full-year 2025 results

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Natera, Inc. furnished a current report stating that on January 11, 2026, it issued a press release with preliminary financial results for its fourth quarter and full fiscal year ended December 31, 2025. The press release is included as Exhibit 99.1, giving investors an early look at the company’s recent performance ahead of full audited results. The company specifies that this information, including Exhibit 99.1, is being furnished rather than filed, which means it is not subject to certain liability provisions under the securities laws or automatically incorporated into other SEC filings unless expressly referenced.

Positive

  • None.

Negative

  • None.
false 0001604821 0001604821 2026-01-11 2026-01-11 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): January 11, 2026

 

 

 

Natera, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-37478   01-0894487

(State or other jurisdiction
of incorporation)

 

(Commission
File Number)

 

(IRS Employer
Identification No.)

 

13011 McCallen Pass
Building A Suite 100

Austin, TX 78753

(Address of principal executive offices, including zip code)

 

(650) 980-9190

(Registrant’s telephone number, including area code)

 

N/A

(Former name or former address, if changed since last report)

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.0001 per share   NTRA   Nasdaq Stock Market LLC
(Nasdaq Global Select Market)

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

 

 

Item 2.02. Results of Operations and Financial Condition.

 

On January 11, 2026, Natera, Inc. (the “Company”) issued a press release announcing preliminary financial results for its fourth quarter and fiscal year ended December 31, 2025. A copy of the press release is furnished herewith as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference.

 

The information in this Current Report on Form 8-K and the accompanying Exhibit 99.1 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing, unless expressly incorporated by reference in such filing.

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit No.   Description  
99.1   Press Release dated January 11, 2026.
104   Cover Page Interactive Data File (formatted as inline XBRL).

 

 

 

  

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  Natera, Inc.
     
  By: /s/ Michael Brophy
    Michael Brophy
    Chief Financial Officer (Principal Financial and Accounting Officer)

 

Dated: January 12, 2026

 

 

 

FAQ

What did Natera (NTRA) disclose in this SEC report?

Natera reported that it issued a press release with preliminary financial results for its fourth quarter and fiscal year ended December 31, 2025, and furnished that press release as an exhibit.

Which period do Natera’s preliminary results in this filing cover?

The preliminary results relate to Natera’s fourth quarter and full fiscal year that ended on December 31, 2025.

Where can investors find the detailed preliminary results for Natera (NTRA)?

The detailed preliminary results are contained in the press release attached as Exhibit 99.1 to the report, which is incorporated by reference in the document.

Are Natera’s preliminary results in this report considered filed financial statements?

No. The company states that the information in the report and Exhibit 99.1 is furnished, not filed, so it is not subject to certain liabilities under Section 18 of the Exchange Act and is not automatically incorporated into other filings.

Who signed this Natera (NTRA) report and in what capacity?

The report was signed on behalf of Natera, Inc. by Michael Brophy, who serves as Chief Financial Officer and principal financial and accounting officer.

What exhibits are included with this Natera (NTRA) report?

The report includes Exhibit 99.1, which is the press release dated January 11, 2026, and Exhibit 104, the cover page interactive data file formatted as inline XBRL.
Natera Inc

NASDAQ:NTRA

NTRA Rankings

NTRA Latest News

NTRA Latest SEC Filings

NTRA Stock Data

33.52B
133.64M
3.2%
96.35%
2.7%
Diagnostics & Research
Services-medical Laboratories
Link
United States
AUSTIN